Prof. Yaakov Naparstek

Dr. Naparstek is a graduate of the Hadassah-Hebrew University Medical School in Jerusalem, Israel. He is board certified in internal medicine, rheumatology and clinical immunology and allergy. Dr. Naparstek has been a research fellow and a visiting professor at the Weizmann Institute of Science, Rehovot, Tuft’s University, Boston, The National Institutes of Health (NIH), Bethesda and Stanford University, California.

Dr. Naparstek is a Professor of Medicine in the Hebrew University, Jerusalem and served as the Chairman of Medicine in the Hadassah University Hospital, as the Director of the Hadassah Clinical Immunology and Rheumatology Center, as well as Hadassah’s Deputy Director for Research and Academic Affairs.

Dr. Naparstek is the incumbent of the Leifferman Chair in Rheumatology. His main research interests are in the field of autoimmunity, SLE, autoimmune arthritis and type 1 diabetes, and on the development of antigen-specific therapeutic modalities and novel drug delivery systems for those diseases.

Dr. Naparstek served as the Chairman of the Board of the Israeli T-Cell Vaccination Center, and was the head and founder of the Israeli SLE Registry. He is currently the Head of the Israeli Cell Therapy and Gene Therapy Committees and a member of many other national and international committees, including the NIH Global Leaders for Precision Medicine, and the International Researchers in Advances in Targeted Therapy.